医疗保健 · Healthcare
打开互动页面（K 线、成交价图）Open interactive page →
RGEN · REPLIGEN CORP
内部人交易（Form 4）· Insider trading · 2026-07-01 – 2026-10-22
REPLIGEN CORP（RGEN）内部人交易：2026-07-01 至 2026-10-22，内部人公开市场买入 —、卖出 $6.0M；高管董事有效买入 —、有效卖出 —。最近申报 2026-10-06。
买入 Bought—
卖出 Sold$6.0M
有效买入 Effective bought—
有效卖出 Effective sold—
最近申报 Recent filings
| 交易日 | 内部人 | 类型 | 股数 | 价格 | 金额 | |
|---|---|---|---|---|---|---|
| 2026-10-05 | Loeillot Olivier Chief Executive Officer, Director | 卖出 Sell | 5,535 | $187.29 | $1.0M | SEC |
| 2026-09-24 | Loeillot Olivier Chief Executive Officer, Director | 卖出 Sell | 12,946 | $190.00 | $2.5M | SEC |
| 2026-09-21 | Loeillot Olivier Chief Executive Officer, Director | 卖出 Sell | 5,426 | $180.00 | $977K | SEC |
| 2026-09-04 | Loeillot Olivier Chief Executive Officer, Director | 卖出 Sell | 3,035 | $165.90 | $504K | SEC |
| 2026-08-20 | Loeillot Olivier Chief Executive Officer, Director | 卖出 Sell | 5,426 | $180.00 | $977K | SEC |
| 2026-07-16 | Garland Jason K CFO | 卖出 Sell | 530 | $150.00 | $80K | SEC |
「有效」= 高管或董事的公开市场主动买卖，排除 10b5-1 计划、行权卖出、缴税卖出、IPO/认购等。
拟出售 Form 144
| 预计出售日 | 申报人 | 股数 | 约金额 | |
|---|---|---|---|---|
| 2026-10-05 | Loeillot Olivier Officer, Director | 4,202 | $798K | 10b5-1 |
| 2026-10-05 | Loeillot Olivier Officer, Director | 1,333 | $238K | 10b5-1 |
| 2026-09-24 | Loeillot Olivier Officer, Director | 12,946 | $2.5M | 10b5-1 |
| 2026-09-21 | Loeillot Olivier Officer, Director | 5,426 | $977K | 10b5-1 |
| 2026-09-04 | Loeillot Olivier Officer, Director | 3,035 | $504K | 10b5-1 |
| 2026-08-20 | Loeillot Olivier Officer, Director | 5,426 | $977K | 10b5-1 |
| 2026-07-16 | Garland Jason K Officer | 530 | $80K | 10b5-1 |
内部人 Insiders
Loeillot Olivier、Garland Jason K